Lead Product(s) : MZ4
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Army Inches Closer To Develop Zika And Dengue Virus Vaccine
Details : In the Phase 1 trial, scientists found that an antibody, named MZ4, was able to have a positive effect on both the Zika virus and the dengue virus.
Product Name : MZ4
Product Type : Vaccine
Upfront Cash : Inapplicable
July 02, 2020
Lead Product(s) : MZ4
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable